Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against other stocks that Jim Cramer discusses in latest lightning round. On Thursday, Jim Cramer ...

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...

The average prediction of analysts places 'Revenue ... According to the collective judgment of analysts, 'Revenues- Core Illumina- Service and other revenue' should come in at $181.45 million.

SHANGHAI, March 4 (Reuters) - China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina (ILMN.O), opens new tab ...

Illumina is a global leader in developing the ... at improving research tasks such as cell state or gene transcription prediction on a broader scale. At the J.P. Morgan Chase Health Care ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers explore cellular behavior mapped across complex tissues. The announcement ...

Illumina and next-gen sequencing (NGS) are synonymous. But to anyone paying attention, the company’s recent emphasis on multiomics has been hard to miss. Indeed, the company has launched both ...